SEC Filing Summary: Hexindai Inc. (Form 6-K)
Business Context and Reporting Period
This Form 6-K was filed by Hexindai Inc., a foreign private issuer, for the month of May 2018. The report was signed by Zhang Qisen (Johnson), Chief Financial Officer, on May 30, 2018. The registrant's principal executive office is located in Beijing, People's Republic of China. The filing indicates the company files annual reports under Form 20-F.
Financial Metrics
The provided filing text does not contain specific financial data. There are no reported values for revenue, profit, cash flow, margins, debt, or liquidity in this document.
Material Changes
The filing text does not provide information regarding material changes versus prior comparable periods.
Guidance, Outlook, and Risks
The filing includes an exhibit index referencing Exhibit 99.1, described as a "Press Release." However, the content of the press release is not included in the provided text. Consequently, no guidance, outlook, management commentary, risks, contingencies, or unusual items can be summarized from the source data.
Key Facts for Investor Verification
- The filing is a procedural Form 6-K referencing a press release (Exhibit 99.1) that is not included in the provided text.
- No financial metrics or operational updates are present in the filing text itself.
- Investors must locate and review the full text of Exhibit 99.1 to obtain the actual news or financial data intended for disclosure.
- The registrant is Hexindai Inc., not Akso Health Group as indicated in the request metadata.